Literature DB >> 9762719

Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome.

T P Krivchenko1, N I Verbovaya.   

Abstract

The role of a depressor factor, atrial natriuretic peptide, in the development of arterial hypertension in adolescents with pubertal hypothalamic syndrome was studied in 52 patients and 13 healthy males aged 13-24 years. The duration of disease was 2-11 years. Radioimmunological methods were used to measure plasma atrial natriuretic peptide, plasma renin activity, and serum aldosterone. Patients with borderline arterial hypertension were found to have a significant reduction in their atrial natriuretic peptide levels, and this correlated directly with the renin-aldosterone system, demonstrating insufficiency of the depressor system in patients with pubertal hypothalamic syndrome and the involvement of atrial natriuretic peptide in the development of arterial hypertension, along with disturbances in the functional relationship between atrial natriuretic peptide and the renin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762719     DOI: 10.1007/bf02464802

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  9 in total

1.  Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.

Authors:  W M Janssen; D de Zeeuw; G K van der Hem; P E de Jong
Journal:  Hypertension       Date:  1992-07       Impact factor: 10.190

Review 2.  Atrial natriuretic factor: a new hormone of cardiac origin.

Authors:  S A Atlas
Journal:  Recent Prog Horm Res       Date:  1986

3.  Correlates of plasma atrial natriuretic factor in health and hypertension.

Authors:  P Montorsi; G Tonolo; J Polonia; D Hepburn; A M Richards
Journal:  Hypertension       Date:  1987-12       Impact factor: 10.190

4.  Emergence of a new cardiovascular control system: atrial natriuretic factor. An introduction.

Authors:  E H Blaine
Journal:  Clin Exp Hypertens A       Date:  1985

Review 5.  [Natriuretic factor--a hormone produced by the atrium].

Authors:  A P Surguchev; R A Grigor'iants; V N Urakov
Journal:  Ter Arkh       Date:  1987       Impact factor: 0.467

6.  Clinical review 53: The endocrinology of vasoactive peptides: synthesis to function.

Authors:  S A Rubin; E R Levin
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

7.  [Effect of natriuretic hormone and changes in the lipid spectrum of erythrocyte membranes on the activity of enzymes of transmembrane ion transport in patients with essential hypertension].

Authors:  L I Gapon; M Zh Shafer; I A Velizhanina; T D Zhuravleva
Journal:  Ter Arkh       Date:  1990       Impact factor: 0.467

8.  Functional-morphological studies on in vitro cardionatrin release.

Authors:  A J de Bold; M L de Bold; I R Sarda
Journal:  J Hypertens Suppl       Date:  1986-06

9.  Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver.

Authors:  R M Arendt; A L Gerbes; D Ritter; E Stangl; P Bach; J Zähringer
Journal:  J Hypertens Suppl       Date:  1986-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.